Alcista
$11.12
Precio del escenario
$33.500
-1.039 (-3.10%)Al cierre
Knowles Corporation is a manufacturer of specialty electronic components. The Company is engaged in manufacturing high-performance capacitors, radio frequency (RF) and microwave filters, advanced medtech microphones, balanced armature speakers, and miniaturization products. The Company’s segments include Precision Devices (PD) and MedTech & Specialty Audio (MSA). Its PD segment is specialized in the design and delivery of high-performance capacitor products and RF solutions primarily serving the defense, medtech, electrification, and industrial markets. Its MSA segment designs and manufactures balanced armature speakers and microphones used in applications that serve the hearing health and premium audio markets. The Company sells its products directly to original equipment manufacturers (OEMs) and to their contract manufacturers and suppliers and through distributors worldwide.
While Knowles Corp has shown strong long-term growth with a year-to-date change of +52.62% and a one-year change of +40.76%, the current technical indicators are concerning. The RSI is at 16.977, indicating the stock is oversold, and the recent insider selling by Cheryl L. Shavers, who reduced her holdings by 16%, raises caution. The forward P/E ratio of 15.24 suggests reasonable valuation, but the stock has dropped 10.81% over the last five days, indicating short-term weakness. Therefore, it may be wise to hold off on buying until the stock stabilizes and shows signs of recovery.
Susquehanna
$40
2026-07-24
Susquehanna
2026-07-24
Precio objetivo
$40
Baird
$44
2026-07-24
Baird
2026-07-24
Precio objetivo
$44
Craig-Hallum
$38
2026-04-24
Craig-Hallum
2026-04-24
Precio objetivo
$38
Baird
$39
2026-04-24
Baird
2026-04-24
Precio objetivo
$39
Craig-Hallum
$30
2026-02-06
Craig-Hallum
2026-02-06
Precio objetivo
$30
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Knowles Launches New ATT A-Series Attenuators for Enhanced RF Solutions

Knowles Introduces New ATT A-Series Attenuators for RF Solutions

Knowles Director Reduces Equity Holdings by 16%

Knowles Director Reduces Equity Exposure by 16%

Knowles Partners with Elucent to Accelerate Surgical Device Production
Knowles Corporation is a manufacturer of specialty electronic components. The Company is engaged in manufacturing high-performance capacitors, radio frequency (RF) and microwave filters, advanced medtech microphones, balanced armature speakers, and miniaturization products. The Company’s segments include Precision Devices (PD) and MedTech & Specialty Audio (MSA). Its PD segment is specialized in the design and delivery of high-performance capacitor products and RF solutions primarily serving the defense, medtech, electrification, and industrial markets. Its MSA segment designs and manufactures balanced armature speakers and microphones used in applications that serve the hearing health and premium audio markets. The Company sells its products directly to original equipment manufacturers (OEMs) and to their contract manufacturers and suppliers and through distributors worldwide. It operates in the Technology sector (HOUSEHOLD AUDIO & VIDEO EQUIPMENT industry).
While Knowles Corp has shown strong long-term growth with a year-to-date change of +52.62% and a one-year change of +40.76%, the current technical indicators are concerning. The RSI is at 16.977, indicating the stock is oversold, and the recent insider selling by Cheryl L. Shavers, who reduced her holdings by 16%, raises caution. The forward P/E ratio of 15.24 suggests reasonable valuation, but the stock has dropped 10.81% over the last five days, indicating short-term weakness. Therefore, it may be wise to hold off on buying until the stock stabilizes and shows signs of recovery.
10 analysts cover KN: 7 rate it Buy, 3 Hold and 0 Sell. The average price target is 27.00.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.